Galectin submits Phase 3 protocol for belapectin after FDA alignment on trial designNov 16Quarterly updatebelapectinGalectin Therapeutics Inc
Galectin says FDA aligned on Phase 3 design for belapectin in MASH cirrhosisAug 14Quarterly updatebelapectinGalectin Therapeutics Inc
Galectin Therapeutics posts results for belapectin hepatic impairment PK studyJul 14Trial updatebelapectinGalectin Therapeutics Inc